Approaches that target the tumor stroma rather than cancer cells, e.g. glypican-1 on CAFs [56] or tumor endothelial marker 8 (TEM8) on CAFs, endothelium and pericytes [92] present as a promising approach moving forward. Here, GPC1 is linked to neoplasm.